Integrating Relative Survival Framework for Survival Extrapolation in Multi-State Models—An Application to Predicting Quality-Adjusted Life Years for Chronic Myeloid Leukemia Patients

Author(s)

Chen EYT1, Dahlén T2, Björkholm M2, Stenke L2, Östensson E2, Clements MS2, Dickman PW2
1Karolinska Institutet, Solna, AB, Sweden, 2Karolinska Institutet, Stockholm, Sweden

Presentation Documents

OBJECTIVES: Continuous-time multi-state models provide a framework for estimating the probability of an individual transitioning from one health state to another together with time spent in each health state. In cost-utility studies, effectiveness often estimated using quality-adjusted life years (QALYs) over a lifetime horizon. Accurately estimating long-term QALYs is crucial in health technology assessment, but this usually requires extrapolating short-term follow-up data. Results are highly sensitive to how the extrapolation is performed. Survival extrapolation using a relative survival framework (i.e., extrapolating after partitioning the all-cause hazard into the expected hazard and the excess hazard) has proven to be superior to direct extrapolation of all-case survival for estimating life expectancy after a cancer diagnosis. However, this approach has not yet been implemented in multi-state models for predicting QALYs.

METHODS: In this study, we propose to incorporate a relative survival framework into survival extrapolation in a multi-state model setting to predict QALYs. We will describe two implementations of this framework. First, we will use continuous-time Markov models, with uncertainty in the transition intensities and health state values incorporated using the delta method. Second, we will predict the QALYs for transition intensities that are a mix of semi-Markov and Markov transitions using discrete event simulation, with uncertainty calculated using the bootstrap. We will apply the approach to estimate QALYs for chronic myeloid leukaemia (CML) patients in Sweden with real-world data from the Swedish CML Registry.

RESULTS: Implementing relative survival framework into survival extrapolation within multi-state models aids predicting QALYs for CML patients in Sweden with more robust estimates.

CONCLUSIONS: Relative survival modelling should be routinely included for extrapolating survival within multi-state models to estimate QALYs with real-world data.

Conference/Value in Health Info

2022-11, ISPOR Europe 2022, Vienna, Austria

Value in Health, Volume 25, Issue 12S (December 2022)

Code

MSR132

Topic

Clinical Outcomes, Methodological & Statistical Research

Topic Subcategory

Artificial Intelligence, Machine Learning, Predictive Analytics, Comparative Effectiveness or Efficacy

Disease

SDC: Oncology

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×